Centogene N.V.
CNTGNASDAQHealthcare
$0.33
+$0.33(+100.00%)
Market Cap$9419082
P/E Ratio—
52W High$0.429
52W Low$0.325
Centogene N.V. (CNTG) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CNTG · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2024Report Date: Aug 21, 2024EPS Actual
-$0.10
Est. -$0.41 · +75.6%
Revenue
—
Est. $0.02B
Fiscal Period
Q3 FY2024
FY ends December
Report Date
Aug 21, 2024
After Market Close
▲ Beat EPS✓ 1-Quarter EPS Beat Streak
CNTG reports quarterly as a NASDAQ-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$3.83
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$3.83
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ▲ Q3 FY2024 | Aug 21, 2024 | -$0.41 | -$0.10 | +75.6% | — | $0.02B | — |
| ◌ Q2 FY2024 | May 15, 2024 | -$0.44 | — | — | — | $0.02B | — |
| ◌ Q1 FY2024 | Jan 18, 2024 | — | — | — | — | — | — |
| — Q3 FY2023 | Sep 7, 2023 | — | -$0.94 | — | $0.03B | $0.01B | +95.4% |
| ▼ Q3 FY2023 | Jul 21, 2023 | -$0.41 | -$0.54 | -31.7% | $0.01B | $0.01B | -3.2% |
| ▼ Q2 FY2023 | May 16, 2023 | -$0.40 | -$0.47 | -17.5% | $0.01B | $0.01B | +3.0% |
| ▼ Q2 FY2023 | Apr 28, 2023 | -$0.40 | -$0.48 | -19.6% | $0.01B | $0.01B | +7.1% |
| ▼ Q4 FY2022 | Dec 22, 2022 | -$0.39 | -$0.47 | -20.5% | $0.01B | $0.01B | +7.7% |
Q3 FY2024
Aug 21, 2024Beat
EPS Actual
-$0.10
EPS Est.
-$0.41
EPS Surpr.
+75.6%
Revenue
—
Q2 FY2024
May 15, 2024
EPS Actual
—
EPS Est.
-$0.44
EPS Surpr.
—
Revenue
—
Q1 FY2024
Jan 18, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2023
Sep 7, 2023
EPS Actual
-$0.94
EPS Est.
—
EPS Surpr.
—
Revenue
$0.03B
Q3 FY2023
Jul 21, 2023Miss
EPS Actual
-$0.54
EPS Est.
-$0.41
EPS Surpr.
-31.7%
Revenue
$0.01B
Q2 FY2023
May 16, 2023Miss
EPS Actual
-$0.47
EPS Est.
-$0.40
EPS Surpr.
-17.5%
Revenue
$0.01B
Q2 FY2023
Apr 28, 2023Miss
EPS Actual
-$0.48
EPS Est.
-$0.40
EPS Surpr.
-19.6%
Revenue
$0.01B
Q4 FY2022
Dec 22, 2022Miss
EPS Actual
-$0.47
EPS Est.
-$0.39
EPS Surpr.
-20.5%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2027 | $-0.38 | $-0.38 | $-0.38 | 1 |
| Q1 FY2027 | $-0.42 | $-0.42 | $-0.42 | 1 |
| Q4 FY2026 | $-0.73 | $-0.73 | $-0.73 | 1 |
| Q3 FY2026 | $-0.50 | $-0.50 | $-0.50 | 1 |
| Q2 FY2026 | $-0.23 | $-0.23 | $-0.23 | 1 |
| Q1 FY2026 | $0.05 | $0.05 | $0.05 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q3 FY2024 | Aug 21, 2024 | +75.6% | $0.16 | $0.16 | +2.33% |
| — Q3 FY2023 | Sep 7, 2023 | — | $1.09 | $1.06 | -2.75% |
| ▼ Q3 FY2023 | Jul 21, 2023 | -31.7% | $1.20 | $1.14 | -5.00% |
| ▼ Q2 FY2023 | May 16, 2023 | -17.5% | $0.85 | $0.80 | -5.65% |
| ▼ Q2 FY2023 | Apr 28, 2023 | -19.6% | $1.21 | $0.81 | -33.06% |
| ▼ Q4 FY2022 | Dec 22, 2022 | -20.5% | $0.92 | $0.84 | -8.89% |
| ▼ Q3 FY2022 | Jul 15, 2022 | -8.0% | $2.18 | $2.20 | +0.92% |
| ▲ Q1 FY2022 | Mar 31, 2022 | +7.9% | $4.09 | $4.21 | +2.93% |
Q3 FY2024+2.33%
Report Date
Aug 21, 2024
EPS Beat/Miss
+75.6%
Price Before
$0.16
Price After
$0.16
Q3 FY2023-2.75%
Report Date
Sep 7, 2023
EPS Beat/Miss
—
Price Before
$1.09
Price After
$1.06
Q3 FY2023-5.00%
Report Date
Jul 21, 2023
EPS Beat/Miss
-31.7%
Price Before
$1.20
Price After
$1.14
Q2 FY2023-5.65%
Report Date
May 16, 2023
EPS Beat/Miss
-17.5%
Price Before
$0.85
Price After
$0.80
Q2 FY2023-33.06%
Report Date
Apr 28, 2023
EPS Beat/Miss
-19.6%
Price Before
$1.21
Price After
$0.81
Q4 FY2022-8.89%
Report Date
Dec 22, 2022
EPS Beat/Miss
-20.5%
Price Before
$0.92
Price After
$0.84
Q3 FY2022+0.92%
Report Date
Jul 15, 2022
EPS Beat/Miss
-8.0%
Price Before
$2.18
Price After
$2.20
Q1 FY2022+2.93%
Report Date
Mar 31, 2022
EPS Beat/Miss
+7.9%
Price Before
$4.09
Price After
$4.21
Avg Beat Reaction+2.63%
Avg Miss Reaction-10.34%
Beat Rate2 / 8 quarters
Largest Move-33.06% (Q2 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CNTG ends December
Centogene N.V. (CNTG) most recently reported earnings on August 21, 2024 for Q3 FY2024, posting EPS of $-0.10 — beating the analyst consensus of $-0.41 by +75.6%. The next CNTG earnings date is expected around September 1, 2026.
Each quarter, investors track CNTG earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CNTG revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CNTG's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CNTG earnings · 5 questionsCentogene N.V.'s next earnings report is expected around September 1, 2026. CNTG typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CNTG historically reports after market close (AMC).
CNTG earnings datewhen is CNTG earningsCNTG next earnings datewhen does CNTG report earningsCNTG earnings calendar
▸ Source: FMP · Centogene N.V. SEC filings · US GAAP · Centogene N.V. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026